ISRG Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 30.99% compared to Intuitive Surgical's net margin of 14.45%. Intuitive Surgical's return on equity of 15.82% beat Boston Scientific's return on equity of 8.96%.

Intuitive Surgical has a consensus price target of $576.03, signalling upside risk potential of 11.94%. On the other hand Boston Scientific has an analysts' consensus of $117.06 which suggests that it could grow by 14.88%. Given that Boston Scientific has higher upside potential than Intuitive Surgical, analysts believe Boston Scientific is more attractive than Intuitive Surgical.

Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.728, suggesting its less volatile than the S&P 500 by 27.188%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.3B, which are smaller than Boston Scientific quarterly revenues of $4.7B. Intuitive Surgical's net income of $698.4M is higher than Boston Scientific's net income of $674M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.45x while Boston Scientific's PE ratio is 74.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.44x versus 8.64x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Integra Lifesciences Holdings has a net margin of 30.99% compared to Intuitive Surgical's net margin of 4.39%. Intuitive Surgical's return on equity of 15.82% beat Integra Lifesciences Holdings's return on equity of -0.45%.

Intuitive Surgical has a consensus price target of $576.03, signalling upside risk potential of 11.94%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $24.75 which suggests that it could grow by 47.23%. Given that Integra Lifesciences Holdings has higher upside potential than Intuitive Surgical, analysts believe Integra Lifesciences Holdings is more attractive than Intuitive Surgical.

Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.241, suggesting its more volatile than the S&P 500 by 24.12%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.3B, which are larger than Integra Lifesciences Holdings quarterly revenues of $442.6M. Intuitive Surgical's net income of $698.4M is higher than Integra Lifesciences Holdings's net income of $19.4M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.45x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.44x versus 0.80x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

LeMaitre Vascular has a net margin of 30.99% compared to Intuitive Surgical's net margin of 20.07%. Intuitive Surgical's return on equity of 15.82% beat LeMaitre Vascular's return on equity of 13.81%.

Intuitive Surgical has a consensus price target of $576.03, signalling upside risk potential of 11.94%. On the other hand LeMaitre Vascular has an analysts' consensus of $105.63 which suggests that it could grow by 15.3%. Given that LeMaitre Vascular has higher upside potential than Intuitive Surgical, analysts believe LeMaitre Vascular is more attractive than Intuitive Surgical.

Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison LeMaitre Vascular has a beta of 0.887, suggesting its less volatile than the S&P 500 by 11.293%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LeMaitre Vascular offers a yield of 0.74% to investors and pays a quarterly dividend of $0.20 per share. Intuitive Surgical pays -- of its earnings as a dividend. LeMaitre Vascular pays out 32.65% of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical quarterly revenues are $2.3B, which are larger than LeMaitre Vascular quarterly revenues of $55.7M. Intuitive Surgical's net income of $698.4M is higher than LeMaitre Vascular's net income of $11.2M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.45x while LeMaitre Vascular's PE ratio is 47.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.44x versus 9.49x for LeMaitre Vascular. Usually stocks with elevated PS ratios are considered overvalued.

Teleflex has a net margin of 30.99% compared to Intuitive Surgical's net margin of -17.18%. Intuitive Surgical's return on equity of 15.82% beat Teleflex's return on equity of 1.57%.

Intuitive Surgical has a consensus price target of $576.03, signalling upside risk potential of 11.94%. On the other hand Teleflex has an analysts' consensus of $161.82 which suggests that it could grow by 19.68%. Given that Teleflex has higher upside potential than Intuitive Surgical, analysts believe Teleflex is more attractive than Intuitive Surgical.

Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Teleflex has a beta of 1.191, suggesting its more volatile than the S&P 500 by 19.095%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Teleflex offers a yield of 1.01% to investors and pays a quarterly dividend of $0.34 per share. Intuitive Surgical pays -- of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical quarterly revenues are $2.3B, which are larger than Teleflex quarterly revenues of $795.4M. Intuitive Surgical's net income of $698.4M is higher than Teleflex's net income of -$136.7M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.45x while Teleflex's PE ratio is 95.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.44x versus 2.09x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.